webinar register page

Webinar banner
GeriMedRisk -Geriatric Clinical Pharmacology Rounds
Title: Clinical Pearls in Osteoporosis


This presentation will address the following topic areas:
1. How do we assess fracture risk? What do we mean by imminent fracture risk?
2. What are the benefits and risks of osteoporosis treatment?
3. Drug holidays: When do we stop therapy, if ever?
4. What do RCT’s of bisphosphonate versus denosumab tell us?
5. When do you measure BMD? Does change in BMD reflect fracture risk reduction?
6. What is Romosozumab?

Presenter: Dr. Rick Adachi, BSc, MD, FRCP(C)

Nov 2, 2021 12:00 PM in Eastern Time (US and Canada)

* Required information


Dr. Rick Adachi
BSc, MD, FRCP(C) @McMaster University, St. Joseph's Healthcare Hamilton
Dr. Rick Adachi is a Professor of Medicine at the Michael G. DeGroote School of Medicine, McMaster University. He is the Actavis Chair for Better Bone Health in Rheumatology. Dr. Adachi has been involved in clinical trials and epidemiologic research. He either holds or is a co-investigator in several CIHR funded studies including the 20 year Canadian Multicentre Osteoporosis Study (CaMOS), and a separate study examining pQCT, HRpQCT and pMRI images of bone structure and strength to determine the relationship of bone structure and muscle to fractures in a subset of CaMOS subjects. Dr Adachi has over 590 peer reviewed publications and is a respected leader in bone research in Canada and Internationally.